Next 10 |
The U.S. Food and Drug Administration (FDA) granted orphan drug designation to Disc Medicine's therapy bitopertin to treat erythropoietic protoporphyria (EPP). EPP is a rare inherited disorder caused by a deficiency of an enzyme called ferrochelatase (FECH), which leads to incre...
Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic Protoporphyria PR Newswire WATERTOWN, Mass. , Dec. 27, 2022 /PRNewswire/ -- Disc Medicine, Inc. ("Disc"), a clinical-stage biopharmaceutical company focused on t...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Throughout much of the new normal, the concept of short-squeeze stocks took off like wildfire. Essentially, this tactic centers on taking a contrarian bet against bearish traders in Wall Street’s version of playing...
Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP) PR Newswire AURORA study designed to evaluate bitopertin as a potential disease-modifying treatment for adults with EPP in the United States ...
NEW YORK, NY / ACCESSWIRE / September 22, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Aerie Pharmaceuticals, Inc. (NA...
NEW YORK, NY / ACCESSWIRE / September 19, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CyberOptics Corporation (NASDAQ...
NEW YORK, NY / ACCESSWIRE / September 2, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Professional Holding Corp. (NASD...
NEW YORK, NY / ACCESSWIRE / August 25, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: BBQ Holdings, Inc. (NASDAQ:BBQ)'s ...
NEW YORK, NY / ACCESSWIRE / August 14, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Gemini Therapeutics, Inc. (NASDAQ:...
Gemini Therapeutics ( NASDAQ: GMTX ) is merging with privately held Disc Medicine in an all-stock transaction. The combined company — which will be headquarters in Watertown, Massachusetts — will be named as Disc Medicine Inc. and trade on Nasdaq ...
News, Short Squeeze, Breakout and More Instantly...
Gemini Therapeutics Inc. Company Name:
GMTX Stock Symbol:
NASDAQ Market:
Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic Protoporphyria PR Newswire WATERTOWN, Mass. , Dec. 27, 2022 /PRNewswire/ -- Disc Medicine, Inc. ("Disc"), a clinical-stage biopharmaceutical company focused on t...
Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP) PR Newswire AURORA study designed to evaluate bitopertin as a potential disease-modifying treatment for adults with EPP in the United States ...